Clinical Transplant-Related Long-term Outcomes of Alternative Donor Allogeneic Transplantation (BMT CTN 1702)
- Status
- COMPLETED
- Phase
- NA
Clinical Trials Related to Acute Myeloid Leukemia
Related studies linked through entity extraction aliases.
Study to Assess Length of Remission With Intensive Chemotherapy in Rapidly Responding AML Patients.
- Status
- UNKNOWN
- Phase
- NA
Gentuzumab Ozogamicin and Midostaurin Combination With Standard Cytarabine and Danunorubi Midostaurin as a Novel Approach to Treating Patients With Newly Diagnosed FLT-3 Mutated Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Study of Standard Intensive Chemotherapy Versus Intensive Chemotherapy With CPX-351 in Adult Patients With Newly Diagnosed AML and Intermediate- or Adverse Genetics
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
CART-19 T Cell in CD19 Positive Relapsed or Refractory Acute Myeloid Leukemia (AML)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Gamma Delta T Cells in AML
- Status
- UNKNOWN
- Phase
- N/A
Investigation of the Gut Microbiota in Patients With Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- NA
CPX-351+GO in Subjects 55 Years Old, or Older, With AML
- Status
- TERMINATED
- Phase
- PHASE1
Venetoclax and Lintuzumab-Ac225 in AML Patients
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Azacitidine, Venetoclax, and Pevonedistat in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Isatuximab in Combination With Chemotherapy in Pediatric Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia
- Status
- TERMINATED
- Phase
- PHASE2
A Study Evaluating the Safety and Efficacy of Idasanutlin in Combination With Cytarabine and Daunorubicin in Patients Newly Diagnosed With Acute Myeloid Leukemia (AML) and the Safety and Efficacy of Idasanutlin in the Maintenance of First AML Complete Remission
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Phase I/II Trial of CPX-351 + Palbociclib in Patients With Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of Venetoclax in Combination With Decitabine in Subjects With Acute Myeloid Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Vorinostat Dose-escalation After Allogeneic Hematopoietic Cell Transplantation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study of Ivosidenib or Enasidenib in Combination With Induction Therapy and Consolidation Therapy, Followed by Maintenance Therapy in Patients With Newly Diagnosed Acute Myeloid Leukemia or Myedysplastic Syndrome EB2, With an IDH1 or IDH2 Mutation, Respectively, Eligible for Intensive Chemotherapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Phase II Study of the Combination of Mitoxantrone, Etoposide and Gemtuzumab Ozogamicin (MEGO) for Patients With Acute Myeloid Leukemia Refractory to Initial Standard Induction Therapy
- Status
- COMPLETED
- Phase
- PHASE2
Gilteritinib vs Midostaurin in FLT3 Mutated Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Zilovertamab Vedotin (MK-2140) (VLS-101) in Participants With Hematologic Malignancies (MK-2140-001)
- Status
- COMPLETED
- Phase
- PHASE1